N-(3,5-bis((Triisopropylsilyl)oxy)phenyl)-3-hydroxy-2-nitrobenzamide, 95%, 50mg

4-Bromophthalic acid, 95.0%, 10g

3-(4-(Trifluoromethyl)benzyl)azetidine hydrochloride, 97.0%, 250mg

3,4-Difluoroaniline>98.0%(GC)(T)100g

4-Butylcyclohexanol, 95.0%, 25g

Tripropylene glycol monobutyl ether, min 95%, for synthesis, 1L, plastic packaging.

(R)-3-(Fluoromethyl)pyrrolidine hydrochloride, 98%, 5g

5-(1-Methyl-1H-1,2,3-triazol-4-yl)isoxazole-3-carboxylic acid, 98%, 100mg

10-Phenyl-9(10H)-acridone>98.0%(HPLC)5g

5-phenyl-4-propyl-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

3-[(3-Methoxybenzoyl)aMino]-4-(4-Methyl-1-piperazinyl)benzoic Acid Methyl Ester, 250mg

3-(1H -Benzoimidazol-2-yl)-2,3-dihydroxy-propionic acid, 95.0%, 500mg

5-Bromo-3-phenylisoxazole, 98%, 100mg